Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker

The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.